Aerie Pharmaceuticals Stock News

DURHAM, N.C.--(BUSINESS WIRE)--Aerie Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

Aerie Pharmaceuticals (AERI) said Gary Sternberg will join the company as chief medical officer, effective Mar. 1.

Aerie Pharmaceuticals (NASDAQ:AERI) is scheduled to announce Q4 earnings results on Thursday, February 24th, after market close.The consensus EPS Estimate is -$0.68 (+13.9% Y/Y) and…

Aerie Pharmaceuticals Inc. (NASDAQ:AERI) traded at $5.82 at close of the session on Tuesday, 02/22/22, made a downward move of -3.00% on its previous days price. Looking at the stock we see that its previous close was $6.00 and the beta (5Y monthly) reads 0.85 with the days price range being $5.79 $6.075. In Why Did Aerie Pharmaceuticals Inc. (NASDAQ: AERI) Drop So Much? Read More »

Let us take a look at five biotech/drug companies, namely, MRNA, EDIT, VIR, EBS and AERI, which are due to release their quarterly results on Feb 24.

DURHAM, N.C.--(BUSINESS WIRE)--AERI 4Q & FY21 Save-the-Date

DURHAM, N.C.--(BUSINESS WIRE)--AERI 4Q & FY21 Save-the-Date

Needham & Company LLC started coverage on shares of Aerie Pharmaceuticals (NASDAQ:AERI) in a research note released on Friday morning, TipRanks reports. The firm issued a buy rating and a $22.00 price target on the stock. Several other research firms have also issued reports on AERI. Zacks Investment Research lowered shares of Aerie Pharmaceuticals from []

In the last trading session, 2.33 million shares of the Aerie Pharmaceuticals Inc. (NASDAQ:AERI) were traded, and its beta was 0.84. Most recently the company’s share price was $8.75, and it changed around -$0.24 or -2.67% from the last close, which brings the market valuation of the company to $420.00M. AERI currently trades at a … Aerie Pharmaceuticals Inc. (NASDAQ: AERI): Would You Buy Today? Read More »

The trading price of Aerie Pharmaceuticals Inc. (NASDAQ:AERI) closed lower on Friday, December 10, closing at $8.99, -2.92% lower than its previous close. >> 7 Top Picks for the Post-Pandemic Economy

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI)s stock price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $14.06 and traded as low as $8.98. Aerie Pharmaceuticals shares last traded at $8.99, with a volume of 1,292,072 shares traded. Several analysts recently issued reports on AERI shares. HC [] The post Aerie Pharmaceuticals (NASDAQ:AERI) Stock Price Crosses Below 200-Day Moving Average of $14.06 appeared first on ETF Daily News .

DURHAM, N.C.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ: AERI, Aerie) announced that Aerie and Santen have entered into an exclusive development and commercialization agreement for Rhopressa®/Rhokiinsa® (netarsudil ophthalmic solution) 0.02% and Rocklatan®/Roclanda® (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005%. The expanded collaboration includes Europe, Commonwealth of Independent States (CIS) countries, China, India, parts of Latin America and the Oceania countri

California State Teachers Retirement System increased its position in shares of Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) by 5.5% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 58,406 shares of the company’s stock after acquiring an additional 3,062 shares during the quarter. California State Teachers […]

In the last trading session, 1.16 million shares of the Aerie Pharmaceuticals Inc. (NASDAQ:AERI) were traded, and its beta was 0.85. Most recently the companys share price was $9.58, and it changed around -$0.12 or -1.24% from the last close, which brings the market valuation of the company to $464.15M. AERI currently trades at a Aerie Pharmaceuticals Inc. (NASDAQ: AERI): Historical Performance And Trend Read More »